<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - COVID-19 Combination Clinical Study
Image Overlay - COVID-19 Combination Clinical Study

COVID-19 Combination Clinical Study

May 12, 2020

COVID-19 Combination Clinical Study

Beaumont Health has launched a new clinical study aimed at treating COVID-19 patients with a combination of naltrexone and ketamine. In spite of the challenges associated with the pandemic, Yourway is maintaining operations across our global network.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat
Come chat with us!
Hello! How can I help you?